Sicart Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61M | Buy |
165,455
+27,862
| +20% | +$1.45M | 3.01% | 11 |
|
|
2025
Q1 | $5.86M | Sell |
137,593
-2,740
| -2% | -$117K | 2.03% | 20 |
|
|
2024
Q4 | $4.29M | Sell |
140,333
-5,970
| -4% | -$182K | 1.53% | 28 |
|
|
2024
Q3 | $3.36M | Buy |
146,303
+320
| +0.2% | +$7.34K | 1.18% | 33 |
|
|
2024
Q2 | $4.22M | Sell |
145,983
-609
| -0.4% | -$17.6K | 1.62% | 28 |
|
|
2024
Q1 | $3.02M | Buy |
146,592
+53,639
| +58% | +$1.11M | 1.11% | 30 |
|
|
2023
Q4 | $2.51M | Sell |
92,953
-2,972
| -3% | -$80.4K | 0.96% | 34 |
|
|
2023
Q3 | $2.84M | Buy |
95,925
+2,955
| +3% | +$87.6K | 1.12% | 32 |
|
|
2023
Q2 | $3.33M | Buy |
92,970
+3,050
| +3% | +$109K | 1.29% | 30 |
|
|
2023
Q1 | $2.11M | Sell |
89,920
-8,070
| -8% | -$189K | 0.82% | 35 |
|
|
2022
Q4 | $2.67M | Sell |
97,990
-38,469
| -28% | -$1.05M | 0.94% | 33 |
|
|
2022
Q3 | $7.35M | Sell |
136,459
-1,430
| -1% | -$77K | 2.61% | 15 |
|
|
2022
Q2 | $5.56M | Buy |
137,889
+4,223
| +3% | +$170K | 1.73% | 24 |
|
|
2022
Q1 | $8.85M | Buy |
133,666
+91,783
| +219% | +$6.08M | 2.29% | 17 |
|
|
2021
Q4 | $4.2M | Buy |
41,883
+41
| +0.1% | +$4.11K | 1.1% | 29 |
|
|
2021
Q3 | $5.23M | Buy |
41,842
+1,322
| +3% | +$165K | 1.43% | 23 |
|
|
2021
Q2 | $5.03M | Buy |
+40,520
| New | +$5.03M | 1.2% | 31 |
|